Therapeutic Strategies for Hepatitis- and Other Infection-Related Immune Thrombocytopenias
To access this article, please choose from the options below
STATEMENT OF CONFLICT OF INTEREST: Roberto Stasi, MD, discloses the following: Honoraria: Amgen, GSK; Speakers’ Bureau: Amgen, GSK.
PII: S0037-1963(08)00205-9
doi:10.1053/j.seminhematol.2008.12.006
© 2009 Elsevier Inc. All rights reserved.
